Comera Life Sciences Inc... (CMRAW)
NASDAQ: CMRAW
· Real-Time Price · USD
0.02
null (null%)
At close: Sep 17, 2024, 10:00 PM
Comera Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.15M | -1.41M | -2.48M | -2.96M | -3.08M | -9.09M | -2.88M | -2.02M | -913.7K | -1.98M | -533.4K |
Depreciation & Amortization | 22.99K | 24.84K | 28.26K | 23.76K | 23.79K | 21.62K | 24.77K | 24.21K | 19.16K | 20.44K | 22.33K |
Stock-Based Compensation | 267.56K | 278.97K | 300.76K | 148.81K | 127.69K | 56.74K | 42.56K | 42.05K | 34.29K | 1.02M | 13.88K |
Other Working Capital | 440.14K | 36.31K | 111.13K | 892.29K | 542.54K | 320.28K | -32.24K | 165.31K | -207.06K | n/a | n/a |
Other Non-Cash Items | -7.92K | 1.41K | -25.35K | -52.7K | 151.08K | 5.11M | -268 | -268 | -268 | 1.23M | 20.3K |
Deferred Income Tax | n/a | -72.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -42.95K | 185.49K | 271.87K | 994.96K | 384.84K | 1.23M | -57.22K | 354.58K | -73.2K | n/a | 109.87K |
Operating Cash Flow | -1.91M | -993.5K | -1.91M | -1.85M | -2.39M | -2.67M | -2.87M | -1.6M | -933.73K | -729.91K | -490.78K |
Capital Expenditures | -2 | -5.65K | -88.36K | -28.58M | -25.15K | -3.45K | n/a | -130.55K | -11.46K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5K | 7.75K | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 11.46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -5.65K | -88.36K | -28.57M | -25.15K | -3.45K | n/a | -130.55K | -11.46K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -453K | -208 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.21M | -63.2K | 1.53M | 1.05M | 145.16K | 3.74M | 222.51K | n/a | 180K | 7.24M | 750K |
Financial Cash Flow | 3.21M | -63.2K | 1.58M | 1.13M | 145.16K | 3.74M | 222.51K | n/a | 2.29M | 7.24M | 750K |
Net Cash Flow | 1.29M | -1.06M | -413.58K | -717.12K | -2.27M | 1.08M | -2.65M | -1.73M | 1.34M | 6.51M | 259.22K |
Free Cash Flow | -1.91M | -999.15K | -1.99M | -30.43M | -2.41M | -2.67M | -2.87M | -1.73M | -945.19K | -729.91K | -490.78K |